It was finally confirmed scientifically.
Recent studies have highlighted that people who use both e-cigarettes and traditional tobacco products are at a significantly greater risk of developing lung cancer compared to those who use only one of these products. This research amplifies longstanding concerns among public health experts about the risks associated with using both smoking and vaping simultaneously.
The study, spearheaded by Marisa Bittoni at Ohio State University’s Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, examined data from nearly 5,000 lung cancer patients and compared it to a control group of approximately 27,300 individuals without cancer. The results revealed that those who used both e-cigarettes and traditional tobacco were eight times more likely to develop lung cancer compared to those in the control group. Additionally, they were four times more likely to face lung cancer than individuals who used only tobacco products.
These findings, published in the Journal of Oncology Research and Therapy, represent the first robust evidence linking a significant increase in lung cancer risk with the combination of smoking and vaping. Dr. Randall Harris, a co-author and professor of epidemiology at the university’s College of Public Health, emphasized that while tobacco smoke is known to contain carcinogenic substances, there is less awareness regarding the harmful components in vape aerosol.
Previous research has already shown that nicotine in e-cigarette vapor can lead to lung cancer in mice, with exposure levels comparable to several years of vaping in humans. The study also noted that e-cigarette aerosols contain various toxic substances beyond nicotine. With the rising popularity of vaping among younger populations, the researchers advocate for further investigation into the health impacts of these products to inform future regulatory measures.
Discussion about this post